Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This entry provides an update on a Phase 1/2 trial evaluating Sernova's Cell Pouch device for islet transplantation in Type 1 Diabetes Mellitus. The study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cell Pouch

Snippet

Sponsor: Sernova Biotherapeutics Inc. | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING